0001140361-12-031524.txt : 20120628
0001140361-12-031524.hdr.sgml : 20120628
20120628152356
ACCESSION NUMBER: 0001140361-12-031524
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120622
FILED AS OF DATE: 20120628
DATE AS OF CHANGE: 20120628
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Morton Andrew C.
CENTRAL INDEX KEY: 0001498511
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10670
FILM NUMBER: 12932459
MAIL ADDRESS:
STREET 1: C/O HANGER ORTHOPEDIC GROUP, INC.
STREET 2: 10910 DOMAIN DRIVE, SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HANGER, INC.
CENTRAL INDEX KEY: 0000722723
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
IRS NUMBER: 840904275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
BUSINESS PHONE: 512-777-3800
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
FORMER COMPANY:
FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: SEQUEL CORP
DATE OF NAME CHANGE: 19890814
FORMER COMPANY:
FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC
DATE OF NAME CHANGE: 19860304
4/A
1
doc1.xml
FORM 4/A
X0305
4/A
2012-06-22
2012-06-25
0
0000722723
HANGER, INC.
HGR
0001498511
Morton Andrew C.
10910 DOMAIN DRIVE
SUITE 300
AUSTIN
TX
78758
0
1
0
0
V.P.-Human Resources
Common Stock
2012-06-22
4
S
0
1100
24.18
D
19206
D
The shares of common stock were sold to cover taxes incurred as a result of the vesting of restricted shares.
These shares were sold at a range of sale prices from $24.05 to $24.38. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
This Amended Form 4 is being filed solely for the purpose of adding a new footnote #2 to this transaction to explain that the price of the securities sold as reflected in Table I is a weighted average price and to provide for the range of sale prices of such securities. The subject footnote was erroneously omitted on the Form 4 filed June 25, 2012.
Includes (i) unvested restricted shares which total 5,000 shares of stock from an initial grant of 5,000 shares of restricted stock made on March 7, 2012; (ii) unvested restricted shares and fully vested shares which total 4,441 shares of stock from an initial grant of 4,900 shares of restricted stock made on March 25, 2011; and (iii) unvested restricted shares and fully vested shares which total 9,765 shares of stock from an initial grant of 12,000 shares of restricted stock made on June 21, 2010. All remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant.
/s/ Jessica Lochmann Allen, Attorney-in-Fact for Andrew C. Morton
2012-06-28